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Abstract
ESR1 has been listed in the Human Obesity Gene Map as candidate gene associated with obesity. Thus, in this study, we investigated the effect
of the ESR1 rs1884051 polymorphism on obesity-related variables, together with their modulations by dietary intake in Korean men. The obesity-related
variables and dietary intake of 3,039 Korean men aged 40-59 years from KoGES database were analyzed. Body weight (P= 0.007), BMI (P=
0.003), waist-hip ratio (= 0.011), fat body mass (P= 0.010), and body fat percentage (P= 0.040) were significantly lower in subjects with the minor
T allele of ESR1 rs1884051 than in subjects carrying the C allele. Moreover, the rs1884051 T allele was associated with a decreased risk of obesity
prevalence (P= 0.040). Among the subjects whose total energy intake was below the median, carrier of the minor T allele of ESR1 rs1884051
had a lower BMI (P= 0.003) when compared with subjects carrying the C allele. In addition, among subjects whose plant protein intake was above
the median, carrier of the minor T allele of ESR1 rs1884051 had a lower BMI (P= 0.044) compared with subjects carrying the C allele. Our findings 
demonstrate that there is a significant association between the ESR1 rs1884051 variant and obesity-related variables and this association can be
potentially modified by dietary energy and plant protein intake.
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Introduction5)
Obesity is a major health concern worldwide and predisposes 
subjects to a high risk of premature mortality through an 
increased risk of many chronic diseases, including type 2 
diabetes, cardiovascular diseases, metabolic syndromes, and 
cancers [1,2]. The primary cause of obesity is known as an 
accumulation of excessive body fat resulting from an imbalance 
of energy intake over physical activity [3]. However, genetic 
variations have recently been estimated to account for 40-70% 
of the population variance in obesity [4,5]. In other words, 
obesity is regarded as a complex multifactorial disease, which 
is affected by genetic variation as well as environmental factors, 
especially diet. Genetic variations may influence on individuals 
to show different predispositions over obesity through controlling 
a balance between energy intake and expenditure [6,7].
Estrogen and its receptors are essential for sexual development 
and reproductive function, but also play a role in protection 
against obesity and regulation of food intake [8,9]. The estrogen 
receptor 1 (ESR1) gene encodes an estrogen receptor, which is 
a ligand-activated transcription factor composed of several 
important domains for hormone binding, DNA binding, and 
activation of transcription [9].
Recently the ESR1 has been listed in the Human Obesity Gene 
Map as candidate gene associated with obesity [10]. The ESR1 
was expressed primarily by adipocytes and it attenuates the 
lipolytic action in subcutaneous fat through up-regulation of the 
number of antilipolytic alpha 2A-adrenergic receptors [11]. ESR1 
polymorphisms have been reported to be associated with obesity- 
related variables, such as BMI and waist circumference [12-15]. 
It was reported earlier that rs9340799 (XbaI in intron 1) of ESR1 
was related with waist circumference and BMI in middle aged 
Japanese women but not in men [12]. In the Framingham Heart 
Study (FHS), ESR1 polymorphisms, rs223469 (PvuII in intron 
1) and rs9340799 (XbaI in intron 1) were associated with waist 
circumference and rs1801132 (C1335G in exon 4) was associated 
with BMI in men, but not in women [13]. However, rs2234693 
and rs9340799 of ESR1 were not associated with obesity in 
Swedish women [14] and Chinese population [15]. These incon-
sistencies might be explained by the differences in ESR1 from 
races and sex-dependent genetic contributions; some of these 
variations might correspond to functionally important mutations, 
but those found in other ethnic and gender groups might not. 
Furthermore, the interaction between genetic variation and 
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dietary intake might affect the phenotype, which might be the 
source of the inconsistent results observed in these previous 
studies.
Therefore, we investigated the influence of ESR1 rs1884051 
genotype on obesity-related phenotypes in the middle-aged Korean 
men, who participated in the Korean Genome Epidemiology 
Study (KoGES). We also evaluated the interaction between the 
ESR1 rs1884051 genotype and dietary intake in relation with 
body mass index (BMI). 
Subjects and Methods
Subjects
3,039 Korean men aged between 40 and 59 years who 
participated in the Korean Genome Epidemiology Study 
(KoGES) in 2001 were used in this study [16]. The KoGES was 
performed as a cohort study to investigate chronic diseases 
(diabetes, hypertension, osteoporosis, obesity and metabolic 
syndrome) in adults aged 40-69 years old. The subjects were 
recruited from two community-based epidemiological studies in 
the rural Ansung and urban Ansan communities from 2001 to 
2008. All subjects were of Korean ancestry. Among the 10,038 
subjects in the KoGES, 3,039 men that were between 40 and 
59 years old and had completed the dietary analysis were 
selected. This protocol used in this study was approved by the 
Institutional Review Board of Ewha Womans University, Seoul, 
South Korea.
Anthropometric variables 
Body weight, height, and waist circumference were measured 
using a standardized procedure: height without shoes was 
measured using an anthropometer, weight in light clothes was 
determined using a weighting scale, and waist circumference 
over the unclothed abdomen at a minimal diameter was 
measured using non-stretchable standard tape. Body composition 
(lean body mass, fat body mass, body fat percentage, and 
waist/hip ratio) was measured using an In-body 3.0 (Biospace 
Co., Ltd, Seoul, Korea). BMI was calculated by dividing the 
weight in kilograms by the height in meters squared. Obesity 
was defined as BMI ≥25 kg/m
2 and body fat percentage > 25%, 
which was based on the WHO Asia-Pacific Area criterion for 
obesity [17].
Blood biochemical measurements
Venous blood was collected after an overnight fast, and all 
plasma samples were subjected to biochemical measurements. 
Fasting glucose, fasting insulin, total cholesterol, HDL cholesterol, 
and triglycerides were measured using a Hitachi 7600 Automatic 
Analyzer (Hitachi, Tokyo, Japan). The level of LDL cholesterol 
was calculated using the following equation, described by 
Friedewald, for individuals with a plasma triglyceride levels <
400 mg/dl [18]: LDL-cholesterol = [Total cholesterol - {HDL- 
cholesterol - (Triglycerides/5)}].
Dietary analysis
Dietary intake was estimated through a food frequency ques-
tionnaire (FFQ) that was developed and validated in the KoGES 
[19]. The correlation coefficients of nutrient intakes between the 
FFQ at the end of the study and the 12-day diet records showed 
0.43 (protein), 0.40 (fat), and 0.64 (carbohydrate) for age, sex, 
de-attenuated and energy-adjusted data. The questionnaire 
consisted of questions on 103 food items, which were combined 
into the 23 nutrients used in the Korean food composition table. 
The data was analyzed to give an average daily dietary intake 
using the Computer-Aided Nutritional Analysis Program (CAN 
Pro) 3.0, which is a nutrient database developed by the Korean 
Nutrition Society [20]. The protein (total, animal, and plant), fat 
(total, animal, and plant), and carbohydrate intake were given 
as percentages of the total daily energy intake. 
Genotyping and SNP selection
Genomic DNA was extracted from whole blood and genotyped 
on an Affymetrix Genome-Wide Human SNP Array 5.0 [16]. 
Among 39 SNPs in and around ESR1 were found from the 
KoGES, 10 SNPs were first eliminated if they deviated from 
Hardy-Weinberg equilibrium (P < 0.05). Then, SNPs with minor 
allele frequencies below 0.05 were eliminated in the analysis. 
Lastly, ESR1 rs1884051, which presented the significant associa-
tions with obesity-related phenotypes, was studied.
Statistical analysis
All statistical analyses were performed using SPSS provided 
in the Windows software (version 17.0; SPSS Inc, Chicago,
  IL) 
with a level of significance at P< 0.05. Allele frequencies were 
calculated by allele counting and the departure from Hardy- 
Weinberg equilibrium was calculated using the chi-square test. 
To determine the most appropriate model, we tested different 
genetic models (dominant, additive and recessive). A recessive 
model, which carriers of 1 or 2 copies of the major allele (n
= 2,387) were grouped and compared with minor allele homo-
zygotes (n = 652), was used. Data for continuous variables was 
presented as mean values ± SEM (standard error of mean). 
Generalized linear models were applied to compare variables on 
the basis of the ESR1 rs1884051 genotype after adjustment for 
covariates. Potential confounding variables were either statistically 
significant in univariate analyses or known to be potentially 
important factors related to genotype or BMI, such as age, 
hypertension, diabetes, thyroid gland disease, dyslipidemia, 




(n = 652) P-value
Height (cm)  167.87 ± 0.11 167.69 ± 0.22 0.469
Weight (kg)  69.52 ± 0.19 68.49 ± 0.36 0.011
BMI (kg/m
2) 24.62 ± 0.06 24.24 ± 0.11 0.003
Waist circumference (cm) 83.80 ± 0.16 84.02 ± 0.30 0.524
Waist-hip ratio  0.90 ± 0.00 0.89 ± 0.00 0.012
Lean body mass (kg) 53.26 ± 0.13 53.73 ± 0.25 0.055
Fat body mass (kg) 15.53 ± 0.10 14.96 ± 0.25 0.011
Body fat percentage (%) 21.88 ± 0.10 21.42 ± 0.20 0.041
Obesity prevalence (n (%))
BMI  ≥25 kg/m
2 1,050 (44.0) 277 (42.5) 0.504
Body fat percentage ≥25% 543 (26.9) 123 (22.5) 0.042
Glucose (mg/dl) 90.11 ± 0.53 89.87 ± 1.01 0.912
Insulin (μIU/ml) 7.17 ± 0.08 7.12 ± 0.16 0.753
Total cholesterol (mg/dl) 195.10 ± 0.73 194.83 ± 1.41 0.917
HDL-cholesterol (mg/dl) 43.16 ± 0.20 43.28 ± 0.38 0.768
LDL-cholesterol (mg/dl) 115.22 ± 0.73 115.09 ± 1.39 0.933
Triglycerides (mg/dl) 183.10 ± 2.58 182.33 ± 5.00 0.892
ESR1 rs1884051 C > T (MAF/HWE) 0.47/0.28
1) The  data  represent  the  means ± SEM  and  P  values  after  adjustment  for  age, 
hypertension, diabetes, thyroid gland disease, dyslipidemia, smoking, and alcohol 
consumption. 
2) If  triglycerides  were  < 400  mg/dl,  LDL-cholesterol = [Total  cholesterol-{HDL 
-cholesterol + (triglyceride/5)}]. 
Table 1. Anthropometric data and blood profiles of subjects with the ESR1
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Fig. 1. Odd Ratio (OR) and 95% confidence interval (95% CI) for obesity based 
on obesity-related phenotypes (BMI and body fat percentage) of subject with 
the  ESR1 rs1884051 genotype
  in Korean men. O d d s  r a t i o s  ( 9 5 %  C I )  i n  t h e  
aspect of the risk allele using a recessive model (CC+TC vs. TT). Cutoffs for obesity 
were based on WHO Asia-Pacific Area criteria for obesity (BMI ≥ 25 kg/m
2 and 
body  fat  percentage  > 25%).
rs1884051 genotype on the risk of obesity (as BMI and body 
fat percentage) was examined using logistic regression analysis, 
after adjustment for covariates, to estimate the odds ratios (ORs) 
and 95% confidence intervals (CI). To determine the interaction 
between the ESR1 rs1884051 genotype and intake of macronu-
trients, subjects were categorized by comparing their level of total 
energy intake and the percentage of energy they obtained from 
protein (total, animal, and plant), fat (total, animal, and plant), 
and carbohydrate with the median levels for these parameters. 
A multivariate interaction model was used to evaluate the 
interactions between the ESR1 rs1884051 genotype and dietary 
macronutrient intake, and their effect on BMI after adjustment 
for covariates. 
Results
Anthropometric and biochemical characteristics
The anthropometric and biochemical characteristics of the 
3,039 subjects are listed in Table 1.
In the recessive model, the ESR1 rs1884051 polymorphism was 
significantly associated with the obesity-related variables, after 
adjustment for age, hypertension, diabetes, thyroid gland disease, 
dyslipidemia, smoking, and alcohol consumption (Table 1). 
Subjects with homozygous minor T allele of ESR1 rs1884051 
had a significantly lower weight (CC+TC 69.52 ± 0.06 kg vs. 
TT 68.49 ± 0.36 kg, P = 0.011), BMI (CC+TC 24.62 ± 0.06 
kg/m
2 vs. TT 24.24 ± 0.11 kg/m
2,  P = 0.003), waist-hip ratio 
(CC+TC 0.90 ± 0.00 vs. TT 0.89 ± 0.00, P = 0.012), fat body 
mass (CC+TC 15.53 ± 0.10 kg 14.96 ± 0.25 kg, P = 0.011), and 
body fat percentage (CC+TC 21.88 ± 0.10% vs. TT 21.42 ±
0.20%, P= 0.041) when compared to those carrying the C allele.
The biochemical characteristics, such as the plasma level of 
glucose, insulin, cholesterol (total, HDL, and LDL), and 
triglycerides, of the subjects did not differ among the ESR1 
rs1884051 polymorphism (Table 1).
The genotype distribution of SNP in ESR1 rs1884051 was in 
the Hardy-Weinberg equilibrium (P= 0.28), and the minor allele 
frequency (MAF) of polymorphism in ESR1 rs182052 was 0.47 
(Table 1). 
Effect of the ESR1 rs1884051 genotype on the risk of obesity 
prevalence
We analyzed whether the ESR1 rs1884051 genotype affected 
the risk of obesity prevalence based on different criteria for 
obesity using logistic regression analysis after adjustment for age, 
hypertension, diabetes, thyroid gland disease, dyslipidemia, 
smoking, and alcohol consumption (Fig. 1). No association 
between ESR1 rs1884051 genotype and the prevalence of obesity, 
which was defined as BMI ≥25 kg/m
2, was observed (CC+TC 
44.0% vs. TT 42.5%, P = 0.504, Table 1). Also, the effect of 
the ESR1 rs1884051 genotype on the risk of obesity prevalence 
was not detected (Fig. 1). When obesity prevalence was defined 
as body fat percentage > 25%, the prevalence of obesity was 
significantly lower in subjects with the homozygous T allele of 
ESR1 rs1884051 than in those carrying the C allele, CC+TC: 
26.9% and TT: 22.5% respectively, after adjustment for 
covariates (Table 1). Moreover, the subjects with the minor T 
allele of ESR1 rs1884051 had a significantly decreased risk of 
obesity than those carrying the C allele (OR = 0.79, 95% CI =






(n = 652) P-value* P-value**
Energy
(kcal)
< 2,053.24 24.52 ± 0.09 23.77 ± 0.16 0.001 0.003
≥2,053.24 24.71 ± 0.08 24.74 ± 0.16 0.841
Protein
(%E)
< 15.80 24.51 ± 0.08 23.96 ± 0.16 0.003 0.200
≥15.80 24.74 ± 0.09 24.52 ± 0.17 0.248
Animal protein 
(%E)
< 6.09 24.60 ± 0.09 24.07 ± 0.17 0.011 0.326
≥6.09 24.64 ± 0.09 24.37 ± 0.16 0.128
Plant protein 
(%E)
< 9.38 24.58 ± 0.08 24.48 ± 0.16 0.530 0.038
≥9.38 24.65 ± 0.09 24.01 ± 0.16 0.001
Fat
(%E)
< 20.60 24.46 ± 0.08 23.92 ± 0.16 0.003 0.205
≥20.60 24.79 ± 0.09 24.56 ± 0.16 0.265
Animal fat
(%E)
< 9.85 24.68 ± 0.09 24.09 ± 0.17 0.003 0.161
≥9.85 24.56 ± 0.09 24.35 ± 0.16 0.235
Plant fat
(%E)
< 9.74 24.67 ± 0.08 24.114 ± 0.17 0.008 0.201
≥9.74 24.57 ± 0.09 24.34 ± 0.16 0.142
Carbohydrate 
(%E)
< 64.10 24.77 ± 0.09 24.52 ± 0.16 0.179 0.296
≥64.10 24.47 ± 0.09 23.94 ± 0.16 0.005
1) The  data  represent  the  means ± SEM  and  P  values  after  adjustment  for  age, 
hypertension, diabetes, thyroid gland disease, dyslipidemia, smoking, and alcohol 
consumption  (* within  genotype,  ** within  gene-diet  interaction). 
2) Total daily energy intake, together with protein, fat, and carbohydrate intake, was 
d e r i v e d  f r o m  t h e  F F Q  ( F o o d  f r e q u e n c y  q u e s t i o n n a ir e ) .
Table 3. The effects of the interaction between the ESR1 rs1884051 genotype 




(n = 652) P-value
Energy (kcal) 2,147.42 ± 11.52 2,120.36 ± 22.06 0.277
Protein (%E) 15.77 ± 0.05 15.84 ± 0.09 0.481
Animal (%E) 6.27 ± 0.05 6.34 ± 0.10 0.523
Plant (%E) 9.49 ± 0.03 9.51 ± 0.06 0.764
Fat (%E) 20.51 ± 0.10 20.57 ± 0.20 0.810
Animal (%E) 10.10 ± 0.09 10.37 ± 0.17 0.163
Plant (%E) 9.76 ± 0.06 9.93 ± 0.11 0.163
Carbohydrate (%E) 64.16 ± 0.14 63.96 ± 0.26 0.483
1) The  data  represent  the  means ± SEM  and  P  values  after  adjustment  for  age, 
hypertension, diabetes, thyroid gland disease, dyslipidemia, smoking, and alcohol 
consumption.
2) Total daily energy intake, together with protein, fat, and carbohydrate intake, was 
d e r i v e d  f r o m  t h e  F F Q  ( F o o d  f r e q u e n c y  q u e s t i o n n a ir e ) .
Table 2. Dietary intake of subjects with the ESR1 rs1884051 genotype in Korean
men
The effects of interaction between the ESR1 rs1884051 genotype 
and dietary intake on BMI 
Dietary intake was analyzed to examine whether the ESR1 
rs1884051 genotype affected dietary macronutrient intake (Table 
2). The polymorphism of ESR1 rs1884051 was not associated 
with the mean values of the total energy intake. Similarly, the 
percentage of energy obtained from protein (total, animal, and 
plant), fat (total, animal, and plant), and carbohydrate consump-
tion were independent of the ESR1 rs1884051 genotype.
We analyzed whether the interaction between the ESR1 
rs1884051 genotype and dietary macronutrient intake affected the 
BMI (Table 3). We sorted each subject by comparing their total 
energy intake and the percentage of energy they obtained from 
protein (total, animal, and plant), fat (total, animal, and plant), 
and carbohydrate consumption with the respective medians. An 
interaction between ESR1 rs1884051 genotype and dietary energy 
intake with respect to BMI was identified (P-interaction = 0.003). 
The homozygous minor T allele of ESR1 rs1884051 was 
associated with lower BMI only in subjects who consumed low 
levels of energy compared to those with carrying the C allele 
(CC+TC 24.52 ± 0.09 kg/m
2 vs. TT 23.77 ± 0.16 kg/m
2,  P <
0.001). On the other hand, there was no significant difference 
with respect to BMI between the ESR1 rs1884051 genotype in 
subjects who consumed high levels of energy. Also, we identified 
significant interaction between ESR1 rs1884051 genotype and 
dietary plant protein intake with respect to BMI (P-interaction
= 0.038). In the group with high plant protein intake, the subjects 
with the homozygous minor T allele of ESR1 rs1884051 had 
a lower BMI than in those carrying the C allele (CC+TC 24.64
± 0.09 kg/m
2 vs. TT 24.01 ± 0.16 kg/m
2, P < 0.001). However, 
in the group with low plant protein intake, the ESR1 rs1884051 
genotype did not affect the BMI. In addition, we could not detect 
an interaction between the ESR1 rs1884051 genotype and the 
percentage of energy obtained from protein (total and animal), 
fat (total, animal, and plant), and carbohydrate consumption with 
respect to BMI.
Discussion
ESR1 on chromosome 6q25 is comprised of 8 exons and 7 
introns with a total size of 140 kilobases [4]. The ESR1 
rs1884051 polymorphism occurs because of the transversion of 
C to T at nucleotide 271749 (NM_001122742) in intron 4 of 
the ESR1 gene, which does not result in amino acid changes. 
This MAF was different from that observed in a European 
population (29.7%), but was similar to that observed in other 
Asian populations (Japanese: 48.9% and Chinese: 45.6%) and 
in an African (41.7%) population obtained from HapMap data. 
In this study, significant associations between obesity-related 
variables and ESR1 rs1884051 polymorphism were identified. 
Subjects with the homozygous minor T allele of ESR1 rs1884051 
showed significantly lower body weight (P = 0.011), BMI (P = 
0.003), waist-hip ratio (P = 0.012), fat body mass (P =0 . 0 1 1 ) ,  
and body fat percentage (P = 0.041) when compared to subjects 
carrying the major C allele after adjustment for age, hypertension, 
diabetes, thyroid gland disease, dyslipidemia, smoking, and 
alcohol consumption. These results were consistent with earlier 
studies that examined other ESR1 polymorphisms [12,13,21]. For 
example, Okura et al. [12] found a similar association with 
obesity-related variables and the rs9340799 (XbaI) polymorphism 
in 2,238 Japanese subjects. Older women (60-79 years) with 
homozygous minor G allele had smaller fat mass by 18% and 
waist circumference by 6% when compared to those carrying 
the homozygous major A allele. On the other hand, no difference 
was found among the rs9340799 genotype for men. The Miae Doo and Yangha Kim 531
Framingham Heart Study (FHS) investigated the association 
between the ESR1 polymorphisms and BMI or waist circum-
ference in 1,763 unrelated men and women [13]. In this 
population, men with the minor homozygous allele for the 
rs2224693 (PvuII) and rs9340799  (XbaI) had lower waist 
circumference than those with the major allele. Also, subjects 
with the minor allele for the rs1801132 (C1335G) had a lower 
BMI when compared to subjects with the major allele in men, 
but not women. In addition, Gallagher et al. [21] reported that 
among 17 ESR1 polymorphisms, rs6902771, rs2431260 and 
rs2175898 were associated with BMI in African Americans from 
the Insulin Resistance Atherosclerosis Family Study. Our results 
provide a new perspective in studying associations between 
genetic variation of ESR1 rs1884051 and the obesity in middle- 
aged Korean men.
Our result showed that the prevalence of obesity, which is 
defined as body fat percentage > 25%, was significantly lower 
in subjects with the minor T allele of ESR1 rs1884051 than in 
subjects carrying the major C allele. Moreover, subjects with 
homozygous minor T allele had a lower risk of obesity by 79%, 
when compared to individuals carrying the C allele. Recently, 
Goulart  et al. [22] showed that women with the variant of 
rs2234693 had a lower prevalence of obesity when compared 
to those with the wild type allele and the rs2234693 poly-
morphism was inversely associated with risk of obesity, which 
was in agreement with our results. These results imply that there 
is a decrease in the prevalence and risk of obesity in subjects 
with the ESR1 rs1884051 T allele. 
We also analyzed the effect of genetic variations on dietary 
macronutrient intake. No significant differences in dietary intake 
of energy and the percentage of energy they obtained from 
protein (total, animal, and plant), fat (total, animal, and plant), 
and carbohydrate were observed among subjects with different 
genotypes of ESR1 rs1884051. These results suggested that 
genetic variations in ESR1 rs1884051 might not influence dietary 
macronutrient intake.
In our study, a significant novel interaction between ESR1 
rs1884051 genotype and dietary intake of energy with respect 
to BMI was identified. Among subjects with low energy intake, 
carriers of the minor T allele of ESR1 rs1884051 had a lower 
BMI than subjects carrying the C allele, whereas for subjects 
with a high energy intake, the ESR1 rs1884051polymorphism 
did not affect BMI. Miyaki et al. [23] found that dietary energy 
intake affected the association between the Trp64Arg polymor-
phism of beta 3-adrenergic receptor (ADRB3) and obesity in 295 
healthy Japanese men. Among the subjects who had a high energy 
intake, the variant of ADRB3 was significantly associated with 
a higher risk of obesity, as compared with the wild type. 
Moreover, the variant of ADRB3 may reduce the risk of obesity 
among subject with proper energy intake. 
Another study reported that the interaction between dietary 
nutrient intake and genetic variation has the potential to decrease 
the risk of obesity [24]. Among subjects who consumed levels 
of polyunsaturated fatty acid (PUFA) above the median level, 
the minor T allele of PDZK1_i33968C > T polymorphism was 
significantly associated with lower BMI, as compared with to 
non-obese subjects carrying the C allele in the Genetics of Lipid 
Lowering Drugs and Diet Network (GOLDN) study. Similarly, 
in our study, a significant novel interaction was observed between 
ESR1 rs1884051 genotype and the percentage of energy they 
obtained from plant protein in relation to their effect on BMI. 
The minor T allele of ESR1 rs1884051 was associated with lower 
BMI in subjects that consumed a high level of dietary plant 
protein. On other hand, there was no difference in BMI for 
subjects that consumed a low level of dietary plant protein 
between the ESR1 rs1884051 genotypes. These findings 
suggested that personalized nutritional research and applications 
should be developed to control the risk of obesity in predisposed 
individuals. For example, if genetically susceptible individuals 
choose a diet with low dietary energy intake and high dietary 
plant protein intake, their risk of obesity can be reduced while 
improving their health.
This study has several limitations. First, this study was 
conducted in 3,039 Korean men aged 40-59 years, thus cannot 
be generalized to other populations. Second, it is generally 
considered that several SNPs among multiple genes may affect 
obesity-related variables. As this study was tested only 1 SNP 
from the single gene, the results have to be confirmed and to 
be examined interaction between other SNPs from the multiple 
genes and ESR1 rs1884051 with respect to BMI in future studies. 
In conclusion, this study demonstrated that the genetic variation 
in ESR1 rs1884051 was directly associated with obesity-related 
variables such as body weight, BMI, waist-hip ratio, fat body 
mass, and body fat percentage in Korean men. Moreover, the 
risk of obesity was also affected by variations in ESR1 rs1884051. 
In particular, with respect to the intake of a low level of dietary 
energy and high level of dietary plant protein, subjects with the 
minor T allele of ESR1 rs1884051 had significantly lower BMI 
than those carrying the C allele. Although these findings will 
need to be reproduced in further studies, this is the first study 
to demonstrate the concept of using a personalized approach to 
control obesity and prevent disease. 
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